Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuway Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10943
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuway Pharma GmbH (Neuway) is a provider of preclinical and clinical development for the treatment of central nervous system diseases. The company provides proprietary CNS drug delivery platform facilitates the transport of active drug substances through the blood-brain barrier. Its technology is based on a protein capsule which allows filling of its lumen with therapeutic active compounds. Neuway utilizes proprietary delivery technology, engineered protein capsules to develop therapeutics for orphan CNS diseases. The company offers EPCs which are deployed in a large variety of therapeutic active substances. It concentrates on orphan brain diseases such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Neuway is headquartered in Bonn, Germany.

Neuway Pharma GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Licensing Agreements 12
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH – Key Competitors 13
Neuway Pharma GmbH – Key Employees 14
Neuway Pharma GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuway Pharma Raises Additional USD3.5 Million in Series A Financing 10
Neuway Pharma Raises USD4 Million in Series A Financing 11
Neuway Pharma Enters into Licensing Agreement with University of Zurich 12
Neuway Pharma GmbH, Key Competitors 13
Neuway Pharma GmbH, Key Employees 14

List of Figures
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuway Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neuway Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adapt Services Limited:企業の戦略・SWOT・財務分析
    SummaryAdapt Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Energiedienst Holding AG (EDHN):企業財務及び戦略的SWOT分析
    Summary Energiedienst Holding AG (Energiedienst) a subsidiary of EnBW Energie Baden-Wurttemberg AG is an electric utility that provides green energy services and supplies hydropower electricity. The utility offers services in the field of heat and distributed generation. It offers services such as g …
  • Mevion Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mevion Medical Systems Inc (Mevion), formerly Still River Systems is a medical equipment company that offers therapy systems. The company offers radiation therapy and proton therapy systems for the treatment of cancer. It provides MEVION S250 proton therapy system designed for preserving tre …
  • Penn National Gaming, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Penn National Gaming, Inc. Merg …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • SP Group A/S (SPG):企業概要、財務及び戦略的SWOT分析
    Summary SP Group A/S (SP Group) is a chemical company. The company manufactures and distributes molded plastic as well as coatings. Its business areas include injection molding, polyurethane, vacuum forming and coating. SP Group’s polyurethane products include ergomat, tinby and TPI polytechniek. Th …
  • TB Alliance(製薬・医療分野):企業M&A動向
    Summary TB Alliance is a healthcare organization. The company discovers and develops drugs for the treatment of tuberculosis disease. Its product pipeline includes isoniazid, rifampin, pyrazinamide, and ethambutol, among others. TB Alliance works with public and private stakeholders, including pharm …
  • Datang International Power Generation Co Ltd:企業の発電所・SWOT分析2018
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Amerisur Resources Plc (AMER):石油・ガス:M&Aディール及び事業提携情報
    Summary Amerisur Resources Plc (Amerisur) is an independent full cycle oil and gas company. It focuses on the exploration, development and production of oil and natural gas in onshore South America, primarily in Colombia and Paraguay. Amerisur has working interests in the Platanillo - OBA cluster, P …
  • KGen Power Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KGen Power Corporation Mergers …
  • Senseonics, Incorporated:企業のM&A・提携動向(医療機器分野)
    Summary Senseonics, Incorporated (Senseonics) formerly Sensors for Medicine and Science, Inc., is a medical device company. The company focuses on the development and commercialization of transformative glucose monitoring products. It develops continuous glucose monitoring system, an implantable con …
  • Intec Pharma ltd. (INTP):企業の財務及び戦略的SWOT分析
    Summary Intec Pharma ltd. (Intec Pharma) is a biopharmaceutical company. It develops and markets improved drug formulations of existing drugs. The company’s pipeline product portfolio comprises drug indications for Parkinson’s disease, insomnia and other diseases. The Accordion Pill, Intec Pharma’s …
  • WD-40 Company (WDFC):企業概要、財務及び戦略的SWOT分析
    Summary WD-40 Company (WD-40) is a multi-purpose lubricant provider. The company’s products provide protection for metal from rust and corrosion, penetrates stuck parts, and offers a strong moisture barrier. It also provides X-14 hard surface cleaners and automatic toilet bowl cleaners, 2000 flushes …
  • Stolt-Nielsen Limited (SNI):企業のM&A・提携動向(石油・ガス分野)
    Summary Stolt-Nielsen Limited (Stolt-Nielsen) formerly Stolt-Nielsen S.A., is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company services include transportation of liquefied petroleum gas (LPG), terminal storage and …
  • HeidelbergCement AG:企業の戦略・SWOT・財務分析
    SummaryHeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …
  • Kirby Corporation (KEX):企業財務及び戦略的SWOT分析
    Summary Kirby Corporation (Kirby) is a provider of marine transportation services. The company offers marine transportation and diesel engine services. It offers transportation of petrochemicals, refined petroleum products, black oil, and other agricultural chemical products by tank barges. Kirby’s …
  • NiSource Inc (NI):石油・ガス:M&Aディール及び事業提携情報
    Summary NiSource Inc (NiSource) is a regulated energy utility. The company distributes natural gas; and generates, transmits and distributes electricity. It produces electricity from coal, gas and hydro sources. NiSource operates electricity transmission systems and natural gas transmission pipeline …
  • Global Power Equipment Group Inc-エネルギー分野:企業M&A・提携分析
    Summary Global Power Equipment Group Inc (Global Power) is a power company that manufactures and distributes auxiliary equipment. The company offers products such as gas and steam turbine auxiliary products, control houses and generator enclosures. It provides repair and maintenance, modification an …
  • ArcelorMittal:企業の戦略・SWOT・財務情報
    ArcelorMittal - Strategy, SWOT and Corporate Finance Report Summary ArcelorMittal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆